# Levetiracetam: UK patient leaflet, explained

Source: patient information leaflet for Levetiracetam 1000 mg Film-Coated Tablets (licence PL 20117/0391), approved by the MHRA. Leaflet dated 2026-07-10. Checked against the source on 2026-11-19.

Original leaflet: https://mhraproducts4853.blob.core.windows.net/docs/a3d06bf6170570ff412bd6624713068a1f215916

Canonical page: https://pestle.health/uk/levetiracetam

## What is levetiracetam for?
Levetiracetam is an antiepileptic medicine used to treat certain types of seizures in epilepsy. It is used on its own in adults and adolescents from 16 years with newly diagnosed partial onset seizures, or as an add-on to other antiepileptic medicines for partial onset, myoclonic and primary generalised tonic-clonic seizures in the age groups the leaflet lists.

## Key facts
- Take it twice a day, once in the morning and once in the evening, at about the same time each day.
- Do not stop treatment without your doctor's advice, as this could increase your seizures. If treatment is stopped it should be done gradually.
- It may make you feel sleepy, especially at the start of treatment or after a dose increase, so do not drive or use machines until you know your ability is not affected.
- Get urgent medical help for signs of a serious allergic reaction, severe skin reactions, sudden kidney problems or serious mental changes.
- Contact your doctor if you have thoughts of harming or killing yourself, or notice important changes in mood or behaviour.

## Who should not take levetiracetam?
- If you are allergic to levetiracetam, pyrrolidone derivatives or any of the other ingredients of this medicine

## Check with a doctor or pharmacist first if
- Kidney problems (your doctor may adjust your dose)
- Any slow down in growth or unexpected puberty development in your child
- Symptoms of depression and/or suicidal thoughts, as a small number of people taking antiepileptics such as levetiracetam have had thoughts of harming or killing themselves
- Family or medical history of irregular heart rhythm (seen on an electrocardiogram), or a disease or treatment that makes you prone to heartbeat irregularities or salt imbalances
- Abnormal thoughts, feeling irritable or reacting more aggressively than usual, or important changes in mood or behaviour
- Seizures becoming worse or happening more often, mainly in the first month of treatment or after a dose increase
- In a very rare early-onset epilepsy linked to SCN8A mutations, seizures that continue or get worse during treatment
- Not for use on its own (monotherapy) in children and adolescents below 16 years

## Side effects that need urgent help
- Weakness, feeling light-headed or dizzy or difficulty breathing, as signs of a serious allergic (anaphylactic) reaction (rare)
- Swelling of the face, lips, tongue and throat (Quincke's oedema) (rare)
- Flu like symptoms and a rash on the face followed by an extended rash with a high temperature, raised liver enzymes, increase in eosinophils, enlarged lymph nodes and involvement of other organs (DRESS) (rare)
- Low urine volume, tiredness, nausea, vomiting, confusion and swelling in the legs, ankles or feet, as signs of a sudden decrease in kidney function (rare)
- Skin rash which may form blisters and look like small targets (erythema multiforme) (rare)
- Widespread rash with blisters and peeling skin, particularly around the mouth, nose, eyes and genitals (Stevens-Johnson syndrome) (rare)
- More severe rash causing skin peeling in more than 30% of the body surface (toxic epidermal necrolysis) (rare)
- Signs of serious mental changes such as confusion, somnolence (sleepiness), amnesia, memory impairment, abnormal behaviour or involuntary or uncontrolled movements, which could be symptoms of an encephalopathy (rare)

## How common are the side effects?
### Very common (More than 1 in 10 people)
- nasopharyngitis
- somnolence (sleepiness)
- headache

### Common (Up to 1 in 10 people)
- anorexia (loss of appetite)
- depression
- hostility or aggression
- anxiety
- insomnia
- nervousness or irritability
- convulsion
- balance disorder (equilibrium disorder)
- dizziness (sensation of unsteadiness)
- lethargy (lack of energy and enthusiasm)
- tremor (involuntary trembling)
- vertigo (sensation of rotation)
- cough
- abdominal pain
- diarrhoea
- dyspepsia (indigestion)
- vomiting
- nausea
- rash
- asthenia/fatigue (tiredness)

### Uncommon (Up to 1 in 100 people)
- decreased number of blood platelets
- decreased number of white blood cells
- weight decrease
- weight increase
- suicide attempt
- suicidal ideation
- mental disorder
- abnormal behaviour
- hallucination
- anger
- confusion
- panic attack
- emotional instability/mood swings
- agitation
- amnesia (loss of memory)
- memory impairment (forgetfulness)
- abnormal coordination/ataxia (impaired coordinated movements)
- paraesthesia (tingling)
- disturbance in attention (loss of concentration)
- diplopia (double vision)
- vision blurred
- elevated/abnormal values in a liver function test
- hair loss
- eczema
- pruritus
- muscle weakness
- myalgia (muscle pain)
- injury

### Rare (Up to 1 in 1,000 people)
- infection
- decreased number of all blood cell types
- severe allergic reactions
- DRESS
- anaphylactic reaction (severe and important allergic reaction)
- Quincke's oedema (swelling of the face, lips, tongue and throat)
- decreased blood sodium concentration
- suicide
- personality disorders (behavioural problems)
- thinking abnormal (slow thinking, unable to concentrate)
- delirium
- encephalopathy
- seizures may become worse or happen more often
- uncontrollable muscle spasms affecting the head, torso and limbs
- difficulty in controlling movements
- hyperkinesia (hyperactivity)
- change of the heart rhythm (Electrocardiogram)
- pancreatitis
- liver failure
- hepatitis
- sudden decrease in kidney function
- skin rash which may form blisters and looks like small targets (erythema multiforme)
- widespread rash with blisters and peeling skin, particularly around the mouth, nose, eyes and genitals (Stevens-Johnson syndrome)
- more severe form of rash causing skin peeling in more than 30% of the body surface (toxic epidermal necrolysis)
- rhabdomyolysis (breakdown of muscle tissue) and associated blood creatine phosphokinase increase (prevalence significantly higher in Japanese patients)
- limp or difficulty walking
- combination of fever, muscle stiffness, unstable blood pressure and heart rate, confusion, low level of consciousness (may be signs of neuroleptic malignant syndrome) (prevalence significantly higher in Japanese patients)

### Very rare (Up to 1 in 10,000 people)
- repeat unwanted thoughts or sensations or the urge to do something over and over again (Obsessive Compulsive Disorder)

## Other medicines the leaflet mentions
- Any other medicines you are taking, have recently taken or might take
- Macrogol (a laxative): do not take it for one hour before and one hour after taking levetiracetam, as it may stop levetiracetam working

## Pregnancy and breastfeeding
Ask your doctor for advice before taking this medicine if you are pregnant, breast-feeding, think you may be pregnant or are planning a baby. It can be used in pregnancy only if your doctor considers it necessary, you should not stop treatment without talking to your doctor, and a risk of birth defects cannot be completely excluded. Breast-feeding is not recommended during treatment.

## How to take it
- Take the number of tablets your doctor has told you, twice a day, once in the morning and once in the evening, at about the same time each day.
- Swallow the tablets with enough liquid, such as a glass of water. You can take them with or without food.
- Adults and adolescents usually take between 1,000 mg and 3,000 mg each day. When taking it on its own, your doctor will start you on a lower dose for 2 weeks.
- Keep taking it for as long as your doctor tells you, and do not stop without their advice.
- If you miss one or more doses, contact your doctor. Do not take a double dose to make up for a forgotten tablet.

---
Reference information taken from the official leaflet. Not medical advice. Other makers of the same medicine may publish slightly different leaflets.
